EP
Elkhorn Partners Portfolio holdings
AUM
$138M
This Quarter Return
+7.1%
1 Year Return
+1.6%
3 Year Return
+7.74%
5 Year Return
+48.56%
10 Year Return
+43.22%
AUM
$186M
AUM Growth
+$186M
(+4.8%)
Cap. Flow
-$2.86M
Cap. Flow
% of AUM
-1.54%
Top 10 Holdings %
Top 10 Hldgs %
96.71%
Holding
43
New
3
Increased
19
Reduced
11
Closed
–
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
$279K |
| 2 |
Bumble
BMBL
|
$188K |
| 3 |
Cadiz
CDZI
|
$118K |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$94.6K |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$74.5K |
Top Sells
| 1 |
Kennedy-Wilson Holdings
KW
|
$2.49M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$782K |
| 3 |
CTO
CTO Realty Growth
CTO
|
$590K |
| 4 |
White Mountains Insurance
WTM
|
$90.9K |
| 5 |
JetBlue
JBLU
|
$41.9K |
Sector Composition
| 1 | Real Estate | 53.13% |
| 2 | Financials | 38.63% |
| 3 | Communication Services | 3.45% |
| 4 | Technology | 1.54% |
| 5 | Materials | 0.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Acacia Research
ACTG
$329M
| $140K | 0.08% |
31,000
+2,200
| +8% | +$9.94K |
|
|
NWLI
27
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $105K | 0.06% |
500
+50
| +11% | +$10.5K |
|
28
Nephros
NEPH
$39.5M
| $104K | 0.06% |
23,712
+8,512
| +56% | +$37.3K |
|
29
Viatris
VTRS
$12.3B
| $63K | 0.03% |
5,800
-3,600
| -38% | -$39.1K |
|
30
Gilead Sciences
GILD
$140B
| $61K | 0.03% |
+1,025
| New | +$61K |
|
31
Amazon
AMZN
$2.44T
| $59K | 0.03% |
18
+16
| +800% | +$52.4K |
|
32
United Airlines
UAL
$34B
| $55K | 0.03% |
1,180
+680
| +136% | +$31.7K |
|
33
MP Materials
MP
$12.6B
| $52K | 0.03% |
900
-100
| -10% | -$5.78K |
|
34
Energy Recovery
ERII
$756M
| $50K | 0.03% |
2,500
| – | – |
|
35
Cardiff Oncology
CRDF
$140M
| $47K | 0.03% |
19,000
+1,700
| +10% | +$4.21K |
|
36
MediaAlpha
MAX
$596M
| $46K | 0.02% |
2,800
+400
| +17% | +$6.57K |
|
37
Five Point Holdings
FPH
$397M
| $41K | 0.02% |
6,700
| – | – |
|
|
BHVN
38
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $41K | 0.02% |
350
| – | – |
|
39
CRISPR Therapeutics
CRSP
$4.71B
| $35K | 0.02% |
550
+200
| +57% | +$12.7K |
|
40
Goldman Sachs
GS
$226B
| $33K | 0.02% |
+100
| New | +$33K |
|
41
Kinder Morgan
KMI
$60B
| $9K | ﹤0.01% |
500
-1,500
| -75% | -$27K |
|
42
Jefferies Financial Group
JEF
$13.4B
| $6K | ﹤0.01% |
175
-75
| -30% | -$2.57K |
|
43
Creative Realities
CREX
$25.2M
| $0 | ﹤0.01% |
78
| – | – |
|